Elisabetta Sereni

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Transitional Type Circulating Tumor Cells Predict Systemic Recurrence and Support Risk Stratification for Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma

  Annals of Surgery · 2025-12-24 · 1 citations

• Transitional type circulating tumor cells predict systemic recurrence and benefit of adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: long-term outcomes of the CLUSTER trial

  Zeitschrift für Gastroenterologie · 2025-09-01

• An Antimicrobial Stewardship Program in Pancreatic Surgery Reduces the Infectious Risk of Colonized Bile, Reducing the Predictive Value of the Intraoperative Bile Culture

  Annals of Surgery · 2025-08-01 · 2 citations

• Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study

  British Journal of Cancer · 2025-05-06 · 7 citations

• Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX

  JAMA Oncology · 2025-01-23 · 14 citations

• Variability in Histological Evaluation of Solid Pseudopapillary Neoplasms: Insights from an International Pathology Survey

  HPB · 2025-01-01

• The diagnostic challenge of pancreatic cystic lesions: a systematic review and meta-analysis of misdiagnosis rates

  Pancreatology · 2024-12-01

• Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9–Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment

  JCO Precision Oncology · 2024-10-01 · 5 citations

• What is the optimal surgical approach for ductal adenocarcinoma of the pancreatic neck? – a retrospective cohort study

  Langenbeck s Archives of Surgery · 2024-07-19 · 9 citations